Merger Notification - Announcement according to § 10 Cartel Act
Sandoz AG; GlaxoSmithKline Plc
BWB/Z-5328
On 25.03.2021 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Sandoz AG (Switzerland) intends to acquire the cephalosporin antibiotic business of GlaxoSmithKline plc (Great Britain).
Economic sector: Manufacture of basic pharmaceutical products
Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 06.05.2021.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
On 19.04.2021 the applicant requested the extension of the deadline for the submission of an application for examination by two weeks, pursuant to § 11 (1a) Cartel Act. The deadline for the submission of an application for examinations by the administrative authorities is extended by two weeks, thus ending on 06.05.2021.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 07.05.2021 .